These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 19269914

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Renal biopsy findings in diabetes mellitus].
    Kharrat M, Kammoun K, Charfeddine K, Yaich S, Zaghdene S, Chaker H, Jarraya F, Ben Hmida M, Jlidi R, Hachicha J.
    Tunis Med; 2007 Mar; 85(3):216-9. PubMed ID: 17668577
    [Abstract] [Full Text] [Related]

  • 43. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
    Nakamura T, Fujiwara N, Sugaya T, Ueda Y, Koide H.
    Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Epidemiology of diabetic nephropathy].
    Rychlík I.
    Vnitr Lek; 2008 May; 54(5):488-93. PubMed ID: 18630634
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Risk factors and management of diabetic nephropathy.
    Ahmed MA, Kishore G, Khader HA, Kasturirangan MN.
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1242-7. PubMed ID: 24231493
    [Abstract] [Full Text] [Related]

  • 50. Status of platelet-lymphocyte aggregation in circulating blood of patients with type 1 diabetes with and without diabetic nephropathy.
    Vitkovsky Y, Kuznik B, Solpov A, Magen E.
    Isr Med Assoc J; 2008 Oct; 10(10):691-4. PubMed ID: 19009947
    [Abstract] [Full Text] [Related]

  • 51. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
    Mitic B, Lazarevic G, Vlahovic P, Rajic M, Stefanovic V.
    Ren Fail; 2008 Oct; 30(9):896-903. PubMed ID: 18925530
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Acute anuric renal failure secondary to intravenous immunoglobulin in diabetic nephropathy.
    Biswas M, Evans PJ.
    Diabetes Res Clin Pract; 2007 Apr; 76(1):139-41. PubMed ID: 16959362
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Nephroprotection from calcium channels blocking agents: a contribution to their probable mechanism of action].
    Colina-Araujo JA, Godoy-Godoy N, Colina-Chourio JA, Avila R, Rincón T.
    Invest Clin; 2008 Sep; 49(3):369-85. PubMed ID: 18846777
    [Abstract] [Full Text] [Related]

  • 57. Difficulty in improving malnutrition and low-grade inflammation in diabetic patients on peritoneal dialysis.
    Park SW, Seo JJ, Bae HS, Kim JY, Kim CD, Park SH, Kim YL.
    Ther Apher Dial; 2008 Dec; 12(6):475-83. PubMed ID: 19140846
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal.
    Sigdel M, Rajbhandari N, Basnet S, Nagila A, Basnet P, Tamrakar BK.
    Nepal Med Coll J; 2008 Dec; 10(4):242-5. PubMed ID: 19558062
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.